Cargando…
A microfluidic cell-migration assay for the prediction of progression-free survival and recurrence time of patients with glioblastoma
Clinical scores, molecular markers and cellular phenotypes have been used to predict clinical outcomes of patients with glioblastoma. However, their clinical use has been hampered by confounders such as patient co-morbidities, by the tumoral heterogeneity of molecular and cellular markers, and by th...
| Autores principales: | , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7855796/ https://www.ncbi.nlm.nih.gov/pubmed/32989283 http://dx.doi.org/10.1038/s41551-020-00621-9 |